---
$id: https://graph.org.ai/products/commodity/51393303
$type: Product
source: UNSPSC
code: "51393303"
title: "Clonazoline"
class: "51393300"
classTitle: "Sympathomimetic or adrenergic drugs, synthesized"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clonazoline

**UNSPSC Code**: 51393303
**Class**: [Sympathomimetic or adrenergic drugs, synthesized](Sympathomimetic or adrenergic drugs, synthesized.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YH9K692U9S. European Medicines Agency schedules Clonazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06729MIG. Clonazoline generally arises in the molecular formula C14H13CLN2. The term CLONAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) CLONAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clonazoline under HS 29332990 and SITC 51573. As of Q4 2014, CLONAZOLINE remains the US FDA Preferred Term for this commodity. Clonazoline bears US NLM identifiers UMLS ID C2699373 and NCI Concept Code C77295. SMILES: CLC1C2C(C(CC3=NCCN3)CC1)CCCC2.

